Abstract
Background: In type 2 diabetes mellitus (DM) lipoprotein abnormalities are the main contributors resulting high atherogenic dyslipidaemia. Non-HDL-cholesterol could be used in screening patients with diabetes, especially in whom LDL-cholesterol levels may not be significantly elevated.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
